Vanda Pharmaceuticals Inc. (VNDA)

NGM – Real Time Price. Currency in USD

5.20

+0.27 (5.38%)

Market open: Aug 12, 2026, 2:48 PM EDT

5.02

+0.09 (1.83%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript

06.08.2026

Vanda Pharmaceuticals Q2 Earnings Call Highlights

Vanda Pharmaceuticals NASDAQ: VNDA reported second-quarter 2026 revenue of $50.5 million, down 4% from a year earlier, as growth in Fanapt and PONVORY was offset by lower HETLIOZ sales amid generic competition and shipment timing. The company reiterated its full-year revenue outlook and said it expects operating expenses to begin declining late this year, with more substantial reductions anticipated in 2027.

05.08.2026

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $0.46 per share a year ago.

Videos

No Data

There is no data to display

Vanda Pharmaceuticals Inc. (VNDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript

Vanda Pharmaceuticals Q2 Earnings Call Highlights

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

Videos

No Data

Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript

Vanda Pharmaceuticals Q2 Earnings Call Highlights

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

Videos

No Data

Search stocks

Vanda Pharmaceuticals Inc. (VNDA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript

Vanda Pharmaceuticals Q2 Earnings Call Highlights

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

Videos

No Data

Vanda Pharmaceuticals Inc. (VNDA) Q2 2026 Earnings Call Transcript

Vanda Pharmaceuticals Q2 Earnings Call Highlights

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

Videos

No Data